AT
TXG icon

American Trust’s 10x Genomics TXG Stock Holding History

American Trust’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,234
Closed -$237K – 473
2022
Q2 		$237K Sell
5,234
-1,773
-25% -$92K 0.02% 368
2022
Q1 		$533K Buy
7,007
+2,426
+53% +$212K 0.04% 231
2021
Q4 		$682K Buy
+4,581
New +$702K 0.05% 134

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Trust's TXG Position: Q3 2022 in Review

American Trust sold out of 10x Genomics (TXG) in Q3 2022, closing a stake of 5,234 shares — an estimated $237K sold.

American Trust first reported a position in TXG in Q4 2021 and held it in 3 quarters. The position peaked at $682K in Q4 2021. 233 funds tracked by Wall St. Rank hold TXG as of Q3 2022.

  • American Trust reported no remaining 10x Genomics position as of Q3 2022 after selling out during the quarter.
  • American Trust sold 5,234 10x Genomics shares in Q3 2022, an estimated $237K.
  • American Trust first reported a position in 10x Genomics in Q4 2021 and held it in 3 quarters.
  • American Trust's 10x Genomics position peaked at $682K in Q4 2021.
  • 233 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2022.

Based on American Trust's 13F filing for Q3 2022, filed 2 Dec 2022.